Skip to search formSkip to main contentSkip to account menu

teneligliptin

Known as: ((2S,4S)-4-(4-(3-Methyl-1-Phenyl-1H-Pyrazol-5-yl)Piperazin-1-yl)Pyrrolidin-2-yl)(1,3-Thiazolidin-3-yl)Methanone 
A long-acting, orally bioavailable, pyrrolidine-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Teneligliptin may also… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Teneligliptin promotes bile acid synthesis and attenuates Lipid Accumulation in Obese Mice by targeting the KLF15-Fgf15 pathway.
Bile acids (BAs) play essential physiological roles not only by facilitating the absorption and transport of nutrients but also… 
2019
2019
A pharmacoeconomic analysis to compare cost-effectiveness of metformin plus teneligliptin with metformin plus glimepiride in patients of type-2 diabetes mellitus
Background: With the available evidence of early combined oral drug therapies being more effective in lowering blood glucose… 
2019
2019
Favourable effect of the sodium‐glucose co‐transporter‐2 inhibitor canagliflozin plus the dipeptidyl peptidase‐4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open‐label…
This multicentre, prospective, randomized, open‐label, blinded‐endpoint, parallel‐group, short‐term (4–5 weeks) controlled trial… 
2018
2018
Teneligliptin add on to monotherapy treatment in patients with type 2 diabetes
Background: In patient with type 2 diabetes (T2D) inadequately controlled on monotherapy, teneligliptin is efficacious and safe… 
2017
2017
Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group…
Dipeptidyl peptidase‐4 (DPP‐4) inhibitors and sodium glucose co‐transporter 2 (SGLT2) inhibitors are frequently used in… 
2017
2017
Long‐term safety and efficacy of canagliflozin as add‐on therapy to teneligliptin in Japanese patients with type 2 diabetes
To evaluate the long‐term safety and efficacy of canagliflozin as add‐on therapy in patients with type 2 diabetes mellitus (T2DM… 
2017
2017
Teneligliptin enhances the beneficial effects of GLP-1 in endothelial cells exposed to hyperglycemic conditions
High-glucose-induced oxidative stress contributes to cardiovascular endothelial damage in diabetes. Glucagon-like peptide 1 (GLP… 
2017
2017
Effect of Hydroxychloroquine on Type 2 Diabetes Mellitus Unresponsive to More Than Two Oral Antidiabetic Agents
Background and aims: The aims of the present study were to evaluate the effectiveness of Hydroxychloroquine as an add-on therapy… 
2016
2016
Efficacy and safety of teneligliptin in addition to insulin therapy in type 2 diabetes mellitus patients on hemodialysis evaluated by continuous glucose monitoring.
2014
2014
STABILITY INDICATING RP-HPLC METHOD FOR DEVELOPMENT AND VALIDATION OF TENELIGLIPTIN HYDROBROMIDE HYDRATE IN PURE AND TABLET DOSAGE FORMS
A simple, rapid, precise and accurate isocratic reversed-phase stability-indicating HPLC method was developed and validated for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)